Clinical Trial Update: A Study of LY3039478 in Participants With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of LY3039478 in participants with advanced cancer completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Neoplasm Metastasis
• Neoplasms

Drugs mentioned

• LY3039478

Snippet

Sponsor: Eli Lilly and Company | Conditions: Neoplasms, Neoplasm Metastasis | Phase 1 | Status: COMPLETED | Results posted: 2025-12-26